Neuberger Berman Group LLC Charles River Laboratories International, Inc. Transaction History

Neuberger Berman Group LLC

  • $130 Billion
  • Q3 2025

A detailed history of Neuberger Berman Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 849,512 shares of CRL stock, worth $143 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
849,512
Previous 694,714 22.28%
Holding current value
$143 Million
Previous $105 Million 26.09%
% of portfolio
0.1%
Previous 0.09%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$145.57 - $178.99 $22.5 Million - $27.7 Million
154,798 Added 22.28%
849,512 $133 Million
Q2 2025

Aug 13, 2025
BUY
$99.75 - $151.89 $10.3 Million - $15.8 Million
103,732 Added 17.55%
694,714 $105 Million
Q1 2025

May 13, 2025
BUY
$150.52 - $190.14 $42.4 Million - $53.6 Million
281,793 Added 91.14%
590,982 $89 Million
Q4 2024

Feb 13, 2025
SELL
$178.58 - $220.69 $673,782 - $832,663
-3,773 Reduced 1.21%
309,189 $57.1 Million
Q3 2024

Nov 14, 2024
BUY
$187.96 - $245.29 $1.03 Million - $1.35 Million
5,505 Added 1.79%
312,962 $61.7 Million
Q2 2024

Nov 14, 2024
BUY
$206.39 - $268.73 $8.39 Million - $10.9 Million
40,634 Added 15.23%
307,457 $63.5 Million
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $8.39 Million - $10.9 Million
40,634 Added 15.23%
307,457 $63.5 Million
Q1 2024

Nov 14, 2024
BUY
$203.52 - $273.43 $1.87 Million - $2.51 Million
9,189 Added 3.57%
266,823 $72.3 Million
Q1 2024

May 13, 2024
BUY
$203.52 - $273.43 $54.3 Million - $73 Million
266,823 New
266,823 $72.3 Million
Q4 2023

Nov 14, 2024
SELL
$164.52 - $238.84 $8.2 Million - $11.9 Million
-49,823 Reduced 16.2%
257,634 $60.9 Million
Q4 2023

Feb 09, 2024
SELL
$164.52 - $238.84 $613,001 - $889,917
-3,726 Reduced 1.43%
257,634 $60.9 Million
Q3 2023

Nov 14, 2023
SELL
$194.44 - $217.61 $252,577 - $282,675
-1,299 Reduced 0.49%
261,360 $51.2 Million
Q2 2023

Aug 11, 2023
BUY
$183.71 - $210.25 $392,771 - $449,514
2,138 Added 0.82%
262,659 $55.2 Million
Q1 2023

May 12, 2023
BUY
$191.89 - $259.92 $712,487 - $965,082
3,713 Added 1.45%
260,521 $52.6 Million
Q4 2022

Feb 13, 2023
SELL
$197.11 - $250.07 $139,159 - $176,549
-706 Reduced 0.27%
256,808 $55.9 Million
Q3 2022

Nov 15, 2022
BUY
$182.44 - $250.54 $1.38 Million - $1.9 Million
7,565 Added 3.03%
257,514 $50.6 Million
Q2 2022

Aug 15, 2022
BUY
$204.13 - $302.4 $828,155 - $1.23 Million
4,057 Added 1.65%
249,949 $53.5 Million
Q1 2022

May 13, 2022
SELL
$255.51 - $362.11 $5.33 Million - $7.56 Million
-20,877 Reduced 7.83%
245,892 $68.8 Million
Q4 2021

Feb 11, 2022
BUY
$351.38 - $448.68 $425,872 - $543,800
1,212 Added 0.46%
266,769 $98.8 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $38.6 Million - $47.5 Million
-103,669 Reduced 28.08%
265,557 $108 Million
Q2 2021

Aug 13, 2021
SELL
$294.17 - $371.65 $13.7 Million - $17.3 Million
-46,454 Reduced 11.18%
369,226 $135 Million
Q1 2021

May 13, 2021
SELL
$249.67 - $299.48 $30.7 Million - $36.8 Million
-122,800 Reduced 22.8%
415,680 $120 Million
Q4 2020

Feb 10, 2021
SELL
$222.0 - $252.62 $2.07 Million - $2.36 Million
-9,342 Reduced 1.71%
538,480 $134 Million
Q3 2020

Nov 12, 2020
SELL
$175.56 - $226.45 $25.1 Million - $32.3 Million
-142,824 Reduced 20.68%
547,822 $124 Million
Q2 2020

Aug 13, 2020
SELL
$118.84 - $189.72 $2.93 Million - $4.68 Million
-24,673 Reduced 3.45%
690,646 $120 Million
Q1 2020

May 14, 2020
BUY
$98.9 - $178.34 $6.62 Million - $11.9 Million
66,938 Added 10.32%
715,319 $90.3 Million
Q4 2019

Feb 12, 2020
BUY
$126.05 - $152.76 $7.55 Million - $9.14 Million
59,863 Added 10.17%
648,381 $99 Million
Q3 2019

Nov 13, 2019
BUY
$125.07 - $143.67 $3.29 Million - $3.78 Million
26,295 Added 4.68%
588,518 $77.9 Million
Q2 2019

Aug 13, 2019
SELL
$123.4 - $148.55 $1.14 Million - $1.37 Million
-9,203 Reduced 1.61%
562,223 $79.8 Million
Q1 2019

May 13, 2019
SELL
$104.82 - $146.73 $1.79 Million - $2.5 Million
-17,066 Reduced 2.9%
571,426 $83 Million
Q4 2018

Feb 12, 2019
SELL
$105.09 - $137.23 $959,786 - $1.25 Million
-9,133 Reduced 1.53%
588,492 $66.6 Million
Q3 2018

Nov 13, 2018
SELL
$112.11 - $134.54 $6.77 Million - $8.12 Million
-60,372 Reduced 9.18%
597,625 $80.4 Million
Q2 2018

Aug 13, 2018
SELL
$102.37 - $117.25 $2.48 Million - $2.84 Million
-24,232 Reduced 3.55%
657,997 $73.9 Million
Q1 2018

May 08, 2018
SELL
$98.19 - $115.2 $3.69 Million - $4.33 Million
-37,590 Reduced 5.22%
682,229 $72.8 Million
Q4 2017

Feb 14, 2018
SELL
$100.43 - $118.09 $6.57 Million - $7.72 Million
-65,405 Reduced 8.33%
719,819 $78.8 Million
Q3 2017

Nov 15, 2017
BUY
$96.72 - $109.26 $75.9 Million - $85.8 Million
785,224
785,224 $84.8 Million

Others Institutions Holding CRL

# of Institutions
643
Shares Held
51.6M
Call Options Held
194K
Put Options Held
174K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email